Elevated APOBEC3B Correlates with Poor Outcomes for Estrogen-Receptor-Positive Breast Cancers

[1]  Wei Zheng,et al.  APOBEC3 deletion polymorphism is associated with breast cancer risk among women of European ancestry. , 2013, Carcinogenesis.

[2]  Chris Sander,et al.  Emerging landscape of oncogenic signatures across human cancers , 2013, Nature Genetics.

[3]  Steven A. Roberts,et al.  An APOBEC cytidine deaminase mutagenesis pattern is widespread in human cancers , 2013, Nature Genetics.

[4]  N. A. Temiz,et al.  Evidence for APOBEC3B mutagenesis in multiple human cancers , 2013, Nature Genetics.

[5]  David T. W. Jones,et al.  Signatures of mutational processes in human cancer , 2013, Nature.

[6]  Wei Lu,et al.  A common deletion in the APOBEC3 genes and breast cancer risk. , 2013, Journal of the National Cancer Institute.

[7]  M. Stratton,et al.  DNA deaminases induce break-associated mutation showers with implication of APOBEC3B and 3A in breast cancer kataegis , 2013, eLife.

[8]  N. A. Temiz,et al.  APOBEC3B is an enzymatic source of mutation in breast cancer , 2013, Nature.

[9]  M. Nussenzweig,et al.  Chromosome translocation, B cell lymphoma, and activation-induced cytidine deaminase. , 2013, Annual review of pathology.

[10]  Ming Li,et al.  Small‐Molecule APOBEC3G DNA Cytosine Deaminase Inhibitors Based on a 4‐Amino‐1,2,4‐triazole‐3‐thiol Scaffold , 2013, ChemMedChem.

[11]  篠原 正信.  APOBEC3B can impair genomic stability by inducing base substitutions in genomic DNA in human cells , 2013 .

[12]  Steven J. M. Jones,et al.  Comprehensive molecular portraits of human breast tumours , 2013 .

[13]  Reuben S Harris,et al.  The APOBEC3 family of retroelement restriction factors. , 2013, Current topics in microbiology and immunology.

[14]  N. Kadowaki,et al.  APOBEC3B can impair genomic stability by inducing base substitutions in genomic DNA in human cells , 2012, Scientific Reports.

[15]  S. Conticello.  Creative deaminases, self‐inflicted damage, and genome evolution , 2012, Annals of the New York Academy of Sciences.

[16]  Andreas Prlic,et al.  BioJava: an open-source framework for bioinformatics in 2012 , 2012, Bioinform..

[17]  Steven J. M. Jones,et al.  Comprehensive molecular portraits of human breast tumors , 2012, Nature.

[18]  A. Børresen-Dale,et al.  Mutational Processes Molding the Genomes of 21 Breast Cancers , 2012, Cell.

[19]  F. Markowetz,et al.  The genomic and transcriptomic architecture of 2,000 breast tumours reveals novel subgroups , 2012, Nature.

[20]  Z. Szallasi,et al.  Implementing an online tool for genome-wide validation of survival-associated biomarkers in ovarian-cancer using microarray data from 1287 patients. , 2012, Endocrine-related cancer.

[21]  N. Krogan,et al.  First-in-class small molecule inhibitors of the single-strand DNA cytosine deaminase APOBEC3G. , 2012, ACS chemical biology.

[22]  Z. Szallasi,et al.  P1-07-18: Expanding an Online Tool for Genome-Wide Validation of Survival-Associated Biomarkers in Breast and Ovarian Cancer Using Microarray Data of 3,862 Patients. , 2011 .

[23]  Patrick Neven,et al.  Assessment of letrozole and tamoxifen alone and in sequence for postmenopausal women with steroid hormone receptor-positive breast cancer: the BIG 1-98 randomised clinical trial at 8·1 years median follow-up. , 2011, The Lancet. Oncology.

[24]  Brigitte L. Arduini,et al.  APOBEC2, a selective inhibitor of TGFβ signaling, regulates left-right axis specification during early embryogenesis. , 2011, Developmental biology.

[25]  U. Strähle,et al.  Lack of Apobec2-related proteins causes a dystrophic muscle phenotype in zebrafish embryos , 2010, The Journal of cell biology.

[26]  W. Brown,et al.  Quantitative profiling of the full APOBEC3 mRNA repertoire in lymphocytes and tissues: implications for HIV-1 restriction , 2010, Nucleic acids research.

[27]  A. Børresen-Dale,et al.  COMPLEX LANDSCAPES OF SOMATIC REARRANGEMENT IN HUMAN BREAST CANCER GENOMES , 2009, Nature.

[28]  M. Neuberger,et al.  Deficiency in APOBEC2 Leads to a Shift in Muscle Fiber Type, Diminished Body Mass, and Myopathy , 2009, The Journal of Biological Chemistry.

[29]  K. Jeang,et al.  Human cellular restriction factors that target HIV-1 replication , 2009, BMC medicine.

[30]  S. O’Brien,et al.  Guidelines for Naming Nonprimate APOBEC3 Genes and Proteins , 2008, Journal of Virology.

[31]  S. Conticello.  The AID/APOBEC family of nucleic acid mutators , 2008, Genome Biology.

[32]  Y. Miki,et al.  Identification of novel deletion polymorphisms in breast cancer. , 2008, International journal of oncology.

[33]  N. Brünner,et al.  Concentrations of TIMP1 mRNA splice variants and TIMP-1 protein are differentially associated with prognosis in primary breast cancer. , 2007, Clinical chemistry.

[34]  M. Neuberger,et al.  Molecular mechanisms of antibody somatic hypermutation. , 2007, Annual review of biochemistry.

[35]  E. Birney,et al.  Patterns of somatic mutation in human cancer genomes , 2007, Nature.

[36]  Mieke Timmermans,et al.  How ADAM-9 and ADAM-11 Differentially From Estrogen Receptor Predict Response to Tamoxifen Treatment in Patients with Recurrent Breast Cancer: a Retrospective Study , 2005, Clinical Cancer Research.

[37]  W. Sauerbrei,et al.  Reporting recommendations for tumor marker prognostic studies (REMARK). , 2005, Journal of the National Cancer Institute.

[38]  Andrew D. Yates,et al.  A screen of the complete protein kinase gene family identifies diverse patterns of somatic mutations in human breast cancer , 2005, Nature Genetics.

[39]  J. Foekens,et al.  Gene-expression profiles to predict distant metastasis of lymph-node-negative primary breast cancer , 2005, The Lancet.

[40]  Yudong D. He,et al.  A Gene-Expression Signature as a Predictor of Survival in Breast Cancer , 2002 .

[41]  Van,et al.  A gene-expression signature as a predictor of survival in breast cancer. , 2002, The New England journal of medicine.

[42]  Christian A. Rees,et al.  Molecular portraits of human breast tumours , 2000, Nature.

[43]  K. Aoyama,et al.  [The method of total heminephroureterectomy--application of mucolysis]. , 1990, Nihon Hinyokika Gakkai zasshi. The japanese journal of urology.

[44]  E. Kaplan,et al.  Nonparametric Estimation from Incomplete Observations , 1958 .